C-SUITE SPECTATE ↗FRIDAY 6 NOVEMBER 2026FRI 6 NOVINDIA EDITIONNEWSLETTERSADVERTISE
SIGN IN ▾
TAX & POLICY1 MIN READ

SEBI reviews India’s accredited-investor framework

The regulator’s latest review puts eligibility, certification and access to private-market products back under scrutiny.

By Spectate Media desk
A realistic Indian investor reviewing portfolio and compliance documents in a Mumbai advisory office.

SEBI has issued a review of the framework for accredited investors, reopening a key regulatory channel through which sophisticated investors can access products or structures with differentiated safeguards.

Accreditation is intended to identify investors with sufficient financial capacity and understanding to evaluate complex or less-standardised opportunities. A workable system can widen the pool of informed capital for alternative funds and private markets while preserving stronger protections for retail investors.

The policy trade-off

If eligibility thresholds, documentation or renewal requirements are too onerous, participation remains narrow and intermediaries have little incentive to build products around the regime. If standards are too loose, accreditation can become a label that shifts risk to investors without proving genuine capacity or sophistication.

Certification agencies and regulated intermediaries will need to translate the revised framework into consistent checks, audit trails and disclosures. Wealth tests alone may not capture liquidity, concentration or an investor’s ability to absorb losses.

What market participants should examine

The practical effect will depend on the exact eligibility tests, validity period, verification responsibilities and treatment of existing accredited investors. Fund managers should also assess whether product terms and risk communication change materially under the reviewed framework.

The reform’s success should be measured by responsible participation and better capital formation, not simply by a larger accreditation count.

Source: SEBI circulars, 5 November 2026. This article is general information, not legal or investment advice.

This article is journalism and commentary. It is not a recommendation to buy or sell any security, and it is not professional advice. Read the full disclaimer.

UP NEXTReliance Q2 FY27: O2C surge masks retail margin pressureRead the next story →

KEEP READING

THE WEEKLY BRIEF

What moved this week, and what it means for your board.

One email every Friday. Unsubscribe in one click.